[1]
WONGWIKROM, W. 2023. A PROSPECTIVE TRIAL OF IODIXANOL 270, 320 (VISIPAQUE) IN PATIENTS WITH RENAL IMPAIRMENT (WHO HAS SERUM CREATININE BETWEEN 1.8-3.0 MH/DL.) UNDERGOING COMPUTED TOMOGRAPHY AND INTRAVENOUS PYELOGRAPHY. The ASEAN Journal of Radiology. 14, 1 (Apr. 2023), 1–4.